14,255 views
What to do if age and comorbidities interfere with chemotherapy? How does cytokinogenetic therapy improve quality of life and accelerate disease regression? In the case of our patient with a primary diagnosis of breast cancer and metastases in the lymph nodes and lung, only cytokinogenetic therapy was used. Most often, cytokinogenetic therapy in monotherapy is used in this age category, because the patient has many comorbidities, and not everyone can tolerate chemotherapy. At the time of the patient's visit to the clinic, the quality of life was 70% according to the Karnofsky scale, she was worried about pain in the shoulder due to enlarged lymph nodes. Before treatment, we noted a formation in the lung of 8.5 by 7.2 millimeters. After treatment, the formation is not visualized, the patient feels one hundred percent, according to her. We can conclude that with the help of cytokinogenetic therapy, it is possible to achieve regression of formations in the lymphatic system and also the lungs. Against the background of cytokinogenetic therapy, in 40% of cases, patients experience regression of the formation, when the tumor process completely disappears. And also according to statistics, against the background of cytokinogenetic therapy, the probability of relapse of cancer decreases three times. More about Cytokinogenetic therapy at oncocareclinic.ru